about
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified ...
Read More
2.09
-0.04
(-1.88%)
92,357
XNAS Volume
XNAS 30 Jun, 2025 11:47 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
IN8bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..